Volume 86, issue 3, Mars 1999

Editorial

Gustave Roussy (1874-1948): a pioneer in oncology (p.241-3)
Christian Nezelof, Geneviève Contesso

Articles originaux

Fotemustine (Muphoran®) in 22 patients with relapses of high-grade cerebral gliomas (p.289-94)
Jean-Pierre Malhaire, Brigitte Lucas, Hélène Simon, Hervé Person, Phong Dam-Hieu, Jean-Paul Labat

Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer (p.295-301)
May Mabro, Pierre Kerbrat et le groupe d’études du granisétron

Breast cancer in Tunisia: clinical and epidemiological study (p.302-6)
Mongi Maalej, Hatem Frikha, Sihem Ben Salem, Jamel Daoud, Noureddine Bouaouina, Mansour Ben Abdallah, Khaled Ben Romdhane

Synthèses

Cell adhesion molecules: expression and function in acute myeloid leukemia (p.265-77)
Xavier Thomas, Bruno Anglaret

Stewart-Treves syndrom arising in posttraumatic lymphedema (p.279-82)
Brigitte Laguerre, Claudia Lefeuvre, Pierre Kerbrat, Mohamed Hassel

High-dose melphalan in patients with multiple myeloma (p.283-8)
Philippe Moreau, Mireille Le Bonniec, Jean-Luc Harousseau

Point sur…

NB 506 (p.255-8)
Amélie Lansiaux, Christian Bailly

Méthodologie

Meta-analyses of randomized trials in oncology: pros and cons (p.259-64)
Catherine Hill, Jean-Pierre Pignon

Tribune libre

Recommendations for medical management of hereditary breast and ovarian cancer: the Inserm-FNCLCC ad hoc committee (p.307-13)
François Eisinger, Nicole Alby, Alain Bremond, Jacques Dauplat, Marc Espié, Paul Janiaud, Frédérique Kuttenn, Jean-Pierre Lebrun, Jean-Pierre Lefranc, Janine Pierret, Hagay Sobol, Dominique Stoppa-Lyonnet, Dominique Thouvenin, Henri Tristant, Josué Feingold